The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Clinical analysis of concurrent chemotherapy and radiotherapy for advanced cervical cancer
Author(s): 
Pages: 138-140
Year: Issue:  2
Journal: Journal of Hainan Medical College

Keyword:  宫颈肿瘤放射疗法抗肿瘤联合化疗方案;
Abstract: 目的:观察同步放化疗治疗晚期宫颈癌的临床疗效,毒副作用及远期并发症.方法:87例Ⅲb期宫颈癌患者,按信封法随机分为同步放化疗组(A组)和单纯放疗组(B组),A组采用顺铂40 mg/d静脉滴注,化疗6个周期,每周重复,同时进行根治性放射治疗,放疗第1天开始行化疗,放疗采用加速器体外照射,Ir192腔内后装治疗,体外剂量45 Gy/25f/5w(17f后中央挡铅),腔内照射A点总剂量42 Gy/6f.单纯放射治疗组仅行单纯放疗,方法同化放组,不行化疗.结果:A、B组近期疗效比较,差异有统计学意义(P<0.05).A组和B组的5年生存率分别为58%和32%.差异有统计学意义(P<0.05),A、B组毒性反应及远期并发症比较,差异无统计学意义(P>0.05).结论:同步放化疗治疗晚期宫颈癌可增强疗效,提高生存率,毒副作用无明显增加.
Related Articles
loading...